# Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine

> **NCT00518427** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 26 (actual)

## Conditions studied

- Diabetes Type 2

## Interventions

- **DRUG:** Insulin Glargine

## Key facts

- **NCT ID:** NCT00518427
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2009-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518427, "Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00518427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*